APA

Nogueira J. A., Ono-Nita S. K., Nita M. E., de Souza M. M. T., do Carmo E. P., Mello E. S., Scapulatempo C., Paranaguá-Vezozzo D. C., Carrilho F. J. & Alves V. A. F. (20090727). 249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients. : BMC cancer.

Chicago

Nogueira Jeronimo A, Ono-Nita Suzane K, Nita Marcelo E, de Souza Marcelo M T, do Carmo Eliane P, Mello Evandro S, Scapulatempo Cristovan, Paranaguá-Vezozzo Denise C, Carrilho Flair J and Alves Venancio A F. 20090727. 249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients. : BMC cancer.

Harvard

Nogueira J. A., Ono-Nita S. K., Nita M. E., de Souza M. M. T., do Carmo E. P., Mello E. S., Scapulatempo C., Paranaguá-Vezozzo D. C., Carrilho F. J. and Alves V. A. F. (20090727). 249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients. : BMC cancer.

MLA

Nogueira Jeronimo A, Ono-Nita Suzane K, Nita Marcelo E, de Souza Marcelo M T, do Carmo Eliane P, Mello Evandro S, Scapulatempo Cristovan, Paranaguá-Vezozzo Denise C, Carrilho Flair J and Alves Venancio A F. 249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients. : BMC cancer. 20090727.